Experience of Clinical Management for Pregnant Women and Newborns with Novel Coronavirus Pneumonia in Tongji Hospital, China
This article focused on the issues of greatest concern of pregnant women including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosti c criteria, inspection precautions, drug treatment options, indications and methods of termination of pregnancy, postpartum fever, breastfeeding considerations, mode of mother-to-child transmission, neonatal isolation and advice on neonatal nursing, to provide valuable experience for better manageme nt of SARS-CoV-2 infection in pregnant women and newborns.
Publication date: Available online 3 June 2020Source: Life SciencesAuthor(s): Nehla Banu, Sandeep Surendra Panikar, Lizbeth Riera Leal, Annie Riera Leal
Publication date: Available online 2 June 2020Source: Life SciencesAuthor(s): Fereshteh Yazdanpanah, Michael R. Hamblin, Nima Rezaei
Publication date: Available online 1 June 2020Source: Life SciencesAuthor(s): Abhjieet Pandey, Ajinkya Nitin Nikam, Ajjappla Basavraj Shreya, Sadhana P. Mutalik, Divya Gopalan, Sanjay Kulkarni, Bharath Singh Padya, Gasper Fernandes, Srinivas Mutalik, Ruth Prassl
Publication date: 1 September 2020Source: Life Sciences, Volume 256Author(s): Fedor Simko, Russel J. Reiter
Authors: Frost DW, Shah R, Melvin L, Galán de Juana M, MacMillan TE, Abdelhalim T, Lai A, Rawal S, Cavalcanti RB PMID: 32493744 [PubMed - as supplied by publisher]
Authors: Boodman C, Lagacé-Wiens P, Bullard J PMID: 32493742 [PubMed - as supplied by publisher]
Authors: Mishra S, Kwong JC, Chan AK, Baral SD PMID: 32493741 [PubMed - as supplied by publisher]
Authors: Liu W, Zhou P, Chen K, Ye Z, Liu F, Li X, He N, Wu Z, Zhang Q, Gong X, Tang Q, Du X, Ying Y, Xu X, Zhang Y, Liu J, Li Y, Shen N, Couban RJ, Ibrahim QI, Guyatt G, Zhai S Abstract BACKGROUND: Antiviral medications are being given empirically to some patients with coronavirus disease 2019 (COVID-19). To support the development of a COVID-19 management guideline, we conducted a systematic review that addressed the benefits and harms of 7 antiviral treatments for COVID-19. METHODS: We searched MEDLINE, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), PubMed and 3 Chinese databases (CNKI, WA...
Authors: Stumpfe FM, Titzmann A, Schneider MO, Stelzl P, Kehl S, Fasching PA, Beckmann MW, Ensser A Abstract In December 2019, cases of pneumonia of unknown cause first started to appear in Wuhan in China; subsequently, a new coronavirus was soon identified as the cause of the illness, now known as Coronavirus Disease 2019 (COVID-19). Since then, infections have been confirmed worldwide in numerous countries, with the number of cases steadily rising. The aim of the present review is to provide an overview of the new severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) and, in particular, to deduce fr...
ham In early December 2019 a cluster of cases of pneumonia of unknown cause was identified in Wuhan, a city of 11 million persons in the People’s Republic of China. Further investigation revealed these cases to result from infection with a newly identified coronavirus, initially termed 2019-nCoV and subsequently SARS-CoV-2. The infection moved rapidly through China, spread to Thailand and Japan, extended into adjacent countries through infected persons travelling by air, eventually reaching multiple countries and continents. Similar to such other coronaviruses as those causing the Middle East respiratory synd...